SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001654954-18-002426
Filing Date
2018-03-12
Accepted
2018-03-12 17:29:18
Documents
5
Effectiveness Date
2018-03-12

Document Format Files

Seq Description Document Type Size
1 DEFA14A cbmg_defa14a.htm DEFA14A 37437
2 IMAGE cbmg_defa14a.jpg GRAPHIC 8253
3 IMAGE cbmg_defa14a000.jpg GRAPHIC 8113
4 IMAGE cbmg_defa14a001.jpg GRAPHIC 8542
5 IMAGE cbmg_defa14a002.jpg GRAPHIC 8848
  Complete submission text file 0001654954-18-002426.txt   64081
Mailing Address 19925 STEVENS CREEK BLVD., SUITE 100 CUPERTINO CA 95014
Business Address 19925 STEVENS CREEK BLVD., SUITE 100 CUPERTINO CA 95014 (408) 973-7884
Cellular Biomedicine Group, Inc. (Filer) CIK: 0001378624 (see all company filings)

IRS No.: 861032927 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36498 | Film No.: 18684526
SIC: 2836 Biological Products, (No Diagnostic Substances)